3i’s Severin Matten: AI turning outside-in due diligence into a ‘prerequisite’
Pharma and life science dealmaking is set for an uptick in 2024, said 3i’s Matten.
3 January 2024•5 mins read
Pharma and life science dealmaking is set for an uptick in 2024, said 3i’s Matten.
PE spots opportunities in horse healthcare: 5 deals
23 October 2026 · 3 mins read
Blackstone spots AI and low-cost interceptors opportunity with Falcata defense platform
21 October 2026 · 2 mins read
Exclusive: MSCP bets on aging water infrastructure with The Rapid Group investment
20 October 2026 · 3 mins read
PE eyes cardiometabolic care amid GLP-1 boom, outpatient shifts: 6 deals
16 October 2026 · 3 mins read
Exclusive: Vista agrees to acquire HID's PKI business unit
16 October 2026 · 3 mins read
ArchiMed’s Denis Ribon details €1.5bn fund deployment plans as AI reshapes healthcare
14 October 2026 · 4 mins read
Exclusive: ATL Partners forms Precise Aerospace & Defense platform
13 October 2026 · 3 mins read
